SAN DIEGO--(BUSINESS WIRE)--Oct. 13, 2005--JMAR Technologies, Inc. [JMAR] announced that the Company has been competitively selected for the award of a Phase I SBIR Grant from the U.S. Army to support research leading to the development of a compact laser system capable of real-time spectrochemical hazard analysis in the field. This new detection approach is based on JMAR's proven BriteLight(TM) technology and offers an improved method of detecting hazardous materials from a safe, remote location. Taking advantage of BriteLight's unique combination of excellent spatial beam quality and high pulse energy, this new laser will be specially designed for adjustable, dual-pulse mode operation to support laser-induced breakdown spectroscopy (LIBS). LIBS techniques are well suited to field analysis as only the laser beam must reach the sample, allowing remote monitoring of hazardous materials or materials situated in difficult to reach locations. With minimal modification, JMAR's diode-pumped, BriteLight(TM) laser will provide the performance, weight and cost advantages needed for a field portable LIBS system.

The Small Business Innovative Research (SBIR) program was developed to stimulate technological innovation in small businesses to meet federal research and development needs. It also fosters commercialization of innovations derived through SBIR support. Phase I of the program is intended to support feasibility studies and proof of concept. Duration of Phase I is typically 6 months and offers up to $100,000 in funding. Following successful completion of the Phase I contract, the Company intends to pursue a Phase II SBIR contract to further advance this new application.

"We are pleased to have this opportunity to support the U.S. Army by working to adapt our modular BriteLight laser to handle the task of remote, non-contact detection of hazardous materials," commented Ronald A. Walrod, President and CEO of JMAR. "This new use of our core laser technology may lead to multiple exciting applications.

This grant further emphasizes the ongoing demand for the BriteLight(TM) system and its unique modular design that allows for optimized adaptability suitable for a wide variety of applications

About BriteLight(TM)

JMAR's BriteLight(TM) Modular Solid State Laser System provides a unique combination of high brightness, short pulse duration, and exceptional beam quality in a modular, compact design. The product also offers research scientists and manufacturing engineers a versatile laser source that can be used for a multitude of applications, including spectrochemical analysis, nanotech scale fabrication, microscopy and soft X-ray source generation.

About JMAR

JMAR Technologies, Inc. is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging over a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries while continuing to carry out research and development for the U.S. Defense Advanced Research Projects Agency (DARPA) and support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotechnology, bioscience and semiconductor industries with its BriteLight(TM) Laser; X-ray Light Source; Compact X-ray Microscope -- for 3D visualization of single cells and polymers; and its X-ray Nano Probe -- enabling interaction, analysis and materials modification at the nano-scale. JMAR also develops, manufactures and markets its BioSentry(TM) microorganism contamination warning system and maintains a strategic alliance for the production of the READ chemical sensor for homeland security, environmental and utility infrastructure industries.

This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the risk that the performance validation tests of the BioSentry Beta units are not successfully completed due to unforeseen issues with the installation and operation of the units outside of the controlled environment of JMAR's facility, delays in completion of the X-ray Microscope and X-ray Nano Probe prototypes and transition to production units, the failure of the technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR's products, failure to obtain market acceptance, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies, delays in receipt and funding of government contracts and those risks detailed in the Company's Form 10-Q for the quarter ended June 30, 2005 and its Form 8-K filed on March 30, 2005 with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.

Contact: JMAR Technologies, Inc. Dennis E. Valentine, 760-602-3292 www.jmar.com orThe Investor Relations Group IR/Media Relations:John Nesbett/Erika Moran, 212-825-3210